A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. - Concepedia

Concepedia

Publication | Closed Access

A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.

268

Citations

53

References

2008

Year

Philip J. Mease, I. Jon Russell, Lesley M. Arnold, Hana Florian, James P. Young, Susan Martin, Uma Sharma

Abstract

Pregabalin at 300, 450, and 600 mg/day was efficacious and safe for treatment of pain associated with FM. Pregabalin monotherapy provides clinically meaningful benefit to patients with FM.

References

	Year	Citations

Page 1